Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance

Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance. A Prospective Single-center Study

Abdominal pain disorders functional (including functional dyspepsia, irritable bowel syndrome, abdominal migraine, functional abdominal pain) is a very common disease in the pediatric population, where classical medical treatment does not always prove effective. This clinical entity has an impact on the individual physiological balance particularly on the autonomic regulation. Studies concerning adults with irritable bowel syndrome, showed significant changes in heart rate variability indices (HRV: heart rate variability).

The study of time and frequency domain analysis of HRV allows noninvasive and reproducible assessment of the cardiac sympathetic and parasympathetic tone.

The investigators hypothesize that the sympathovagal balance could be altered in children in case of prolonged nociceptive stress as the investigators find it especially in irritable bowel syndrome and functional abdominal pain. In recent years, the control of pediatric pain experienced considerable growth through hypnosis techniques and several studies have shown analgesic efficacy with a beneficial effect in terms of quality of life in children.

Our study aims to assess the impact of the hypno-analgesia treatment of Abdominal pain disorders functional on sympathovagal balance. The investigators propose to realize in 7 to 18 years old children with Abdominal pain disorders functional a single center prospective study to highlight after a standardized hypnosis program, changes in the time and frequency domain indices of heart rate variability and clinical or quality of life parameters. The primary endpoint will be the high frequency HF indice. Secondary endpoints will be the other indices of HRV (Ptot, VLF, LF, ratio LF / HF, SDNN, SDANN, pNN50, RMSSD), the Quality of Life Questionnaire values (PedsQL ™ 4.0) a pain scale and the composite score of Francis.

Study Overview

Status

Terminated

Conditions

Study Type

Observational

Enrollment (Actual)

8

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint Etienne, France, 42055
        • Centre Hospitalier Universitaire de Saint Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Indices of autonomic nervous system in a pediatric population with Abdominal pain disorders functional

Description

Inclusion Criteria:

  • Parents affiliates or entitled to a social security scheme
  • Consent form signed by the holder of parental authority

Exclusion Criteria:

  • Child with pathologies reaching the central nervous system or the brain stem.
  • Children with a severe pathology of cardio-respiratory or heart being referred to treatment.
  • Children requiring emergency surgery or trauma or septic or inflammatory context.
  • Children with psychiatric disorders or mental retardation proven.
  • Children who have already used the earlier hypnosis.
  • Children not speaking French language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
high frequency
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
composite score of Francis
Time Frame: One month after the hypno-analgesic therapeutic program
severity scale of syndrome (pain intensity)
One month after the hypno-analgesic therapeutic program
Pediatric Quality of Life inventory
Time Frame: One month after the hypno-analgesic therapeutic program
One month after the hypno-analgesic therapeutic program
a chronic abdominal pain scale
Time Frame: One month after the hypno-analgesic therapeutic program
adaptation of Francis composite scale for chronic abdominal pain
One month after the hypno-analgesic therapeutic program
a severity of functional dyspepsia scale
Time Frame: One month after the hypno-analgesic therapeutic program
adaptation of Francis composite scale for functional dyspepsia
One month after the hypno-analgesic therapeutic program
a severity of abdominal migraine scale
Time Frame: One month after the hypno-analgesic therapeutic program
adaptation of Francis composite scale for abdominal migraine
One month after the hypno-analgesic therapeutic program
SDNN (standard deviation of all NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
SDANN (standard deviation of the averages of NN intervals in all 5 min segments of the entire recording)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
RMSSD (the square root of the mean of the sum of the squares of difference between adjacent NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
pNN50 (the number of pairs of adjacent NN intervals differing by more than 50 ms dived by the total number of all NN intervals)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
TP (total power)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
VLF (very low frequency component)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
LF (low frequency component)
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program
ratio LF/ HF
Time Frame: One month after the hypno-analgesic therapeutic program
measured with the holter
One month after the hypno-analgesic therapeutic program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hugues PATURAL, MD PhD, Centre Hospitalier Universitaire de Saint Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 31, 2017

Primary Completion (ACTUAL)

January 31, 2019

Study Completion (ACTUAL)

May 29, 2019

Study Registration Dates

First Submitted

June 21, 2016

First Submitted That Met QC Criteria

July 12, 2016

First Posted (ESTIMATE)

July 13, 2016

Study Record Updates

Last Update Posted (ACTUAL)

November 7, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Pain

3
Subscribe